TileDB

📍 Cambridge, United States🗓 Founded 2017👥 69 employees💰 Last funded Oct 2023
TileDB is foundational software designed by scientists for scientific discovery. TileDB structures all data types, including that data that does not fit into relational databases built for structured tabular data. Built on a powerful shape-shifting array database, TileDB handles the complexities of non-traditional “unstructured” multimodal data, such as genomic variants, bulk and single-cell transcriptomics, proteomics, biomedical imaging, as well as the frontier data of the future. Used by science and data teams within big pharma and biotechs to power their multiomic FAIR data platforms, TileDB is the destination for scientific breakthroughs where frontier multimodal data is driving drug discovery.
10
Total investors
1
Early stage
2
Mid stage
7
Late stage
2017
Founded
Investor geography2 countries
United States
8
Netherlands
1
Investor activity2017–2023 · investors recorded per year
201712021220237
Recent (last 2y)Earlier
Frequently asked questions
Who invested in TileDB?
TileDB has 10 investors on record on gritt.io, including 1 early-stage backers, 2 mid-stage and 7 late-stage investors.
When did TileDB last raise funding?
The most recent investment in TileDB recorded on gritt.io was in October 2023.
When was TileDB founded?
TileDB was founded in 2017.
What industry is TileDB in?
TileDB operates in Software Development. Find similar Software Development investors on gritt.io.
Where is TileDB based?
TileDB is headquartered in Cambridge, United States.